| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. | Can J Clin Pharmacol | 2006 | 2.08 |
| 2 | Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. | J Clin Psychiatry | 2008 | 1.61 |
| 3 | Do formulation switches exacerbate existing medical illness? Results of an open-label transition to orally disintegrating risperidone tablets. | Hum Psychopharmacol | 2007 | 0.79 |
| 4 | Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials. | Int Clin Psychopharmacol | 2005 | 0.76 |